Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemia in Remission”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02270463
What this trial is testing

SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission

Who this might be right for
Acute Myeloid Leukemia
Stemline Therapeutics, Inc. 16
Early research (Phase 1)Study completedNCT01578109
What this trial is testing

Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD Mutation
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Study completedNCT00313586
What this trial is testing

Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+12 more
National Cancer Institute (NCI) 197
Not applicableEnded earlyNCT05224661
What this trial is testing

Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events

Who this might be right for
Acute Myeloid Leukemia in Remission
Center for International Blood and Marrow Transplant Research 303
Testing effectiveness (Phase 2)Looking for participantsNCT05917405
What this trial is testing

Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

Who this might be right for
Acute Myeloid Leukemia in Remission
Nantes University Hospital 302
Testing effectiveness (Phase 2)Study completedNCT00795769
What this trial is testing

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more
Fred Hutchinson Cancer Center 49
Large-scale testing (Phase 3)Study completedNCT01191957
What this trial is testing

Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogeneic Hematopoetic Stem Cells Transplant (HSCT) in AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Gruppo Italiano Trapianto di Midollo Osseo 252
Testing effectiveness (Phase 2)Ended earlyNCT01159067
What this trial is testing

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Who this might be right for
Iron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more
City of Hope Medical Center 1
Early research (Phase 1)Study completedNCT02083250
What this trial is testing

Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionAllogeneic Hematopoietic Stem Cell Transplantation Recipient+4 more
M.D. Anderson Cancer Center 70
Large-scale testing (Phase 3)Study completedNCT02085408
What this trial is testing

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
ECOG-ACRIN Cancer Research Group 727
Testing effectiveness (Phase 2)Study completedNCT02566304
What this trial is testing

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia in RemissionAplastic Anemia+12 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 35
Testing effectiveness (Phase 2)Study completedNCT00691015
What this trial is testing

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Barbara Ann Karmanos Cancer Institute 48
Large-scale testing (Phase 3)Ended earlyNCT05413915
What this trial is testing

Asciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CML

Who this might be right for
Chronic Myeloid LeukemiaChronic Myeloid Leukemia, BCR/ABL-PositiveChronic Myeloid Leukemia in Remission
Sarit Assouline 8
Testing effectiveness (Phase 2)UnknownNCT04043676
What this trial is testing

Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Fundación Teófilo Hernando, Spain 40
Testing effectiveness (Phase 2)Ended earlyNCT00043810
What this trial is testing

Study of Gelonin Purging of Autologous Stem Cells for Transplantation

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT01360125
What this trial is testing

S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy

Who this might be right for
Leukemia
SWOG Cancer Research Network 310
Testing effectiveness (Phase 2)Study completedNCT00416624
What this trial is testing

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 239
Testing effectiveness (Phase 2)Study completedNCT00053989
What this trial is testing

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Roswell Park Cancer Institute 41
Testing effectiveness (Phase 2)Study completedNCT01273766
What this trial is testing

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+133 more
Wake Forest University Health Sciences 16
Large-scale testing (Phase 3)Study completedNCT00003687
What this trial is testing

Treatment for Chronic Pain in Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
NCIC Clinical Trials Group 87
Next Page